To confirm the prognostic significance of TGF-β subtypes in women with ovarian tumors, our research explored the correlation between the expression level of TGF-β subtypes and the survival of ovarian carcinoma patients. This evidence concerns the gene TGFB1 and ovarian neoplasm.